More Great News About Vitamin D.
First randomized controlled trial on Vitamin D and COVID-19. In the control group (that was not taking Vitamin D) 50 percent required ICU admission. IN the Vitamin D group, only 2 percent were admitted to the ICU.
The Study Highlights
- The vitamin D endocrine system have a variety of actions on cells and tissues involved in COVID-19 progression.
- Early vitamin D treatment to hospitalized COVID-19 patients significantly reduced intensive care unit admissions
- Vitamin D seems to be able to reduce severity of the COVID-19.
Parallel pilot randomized open label, double-masked clinical trial at a University hospital setting (Reina Sofia University Hospital, Córdoba Spain.)
76 consecutive patients hospitalized with COVID-19 infection, clinical picture of acute respiratory infection, confirmed by a radiographic pattern of viral pneumonia and by a positive SARS-CoV-2 PCR with CURB65 severity scale (recommending hospital admission in case of total score > 1).
Conclusion of the Study
Pilot study demonstrated that administration of a high dose of Calcifediol or 25-hydroxyvitamin D, a main metabolite of vitamin D endocrine system, significantly reduced the need for ICU treatment of patients requiring hospitalization due to proven COVID-19. Calcifediol seems to be able to reduce severity of the disease, but larger trials with groups properly matched will be required to show a definitive answer.
CLICK HERE for the full article
OTHER BLOGS ABOUT VITAMIN D
NOTE – my role in NOT to diagnose, treat or give you medical information. My role as a health coach is to education on the role of lifestyle in supporting optimal health. It is with this purpose, that I share credible research on the role that vitamin D plays during this pandemic. .